<DOC>
	<DOC>NCT02942680</DOC>
	<brief_summary>evaluate the safety of preoperative aspirin therapy when performing bypass surgery in conditions of artificial blood circulation</brief_summary>
	<brief_title>Efficacy and Safety of Aspirin Therapy With CABG</brief_title>
	<detailed_description>The hypothesis of the study was that aspirin therapy started 24 hours before CABG is safe. The effectiveness of this hypothesis will be assessed by the presence of a 30-day period after CABG myocardial infarction, ischemic stroke, repeat revascularizations</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Patients 18 years of age or older Patient able to give informed consent Missing consent Urgent or emergent surgery Offpump CABG Ð atient has clear indication for anticoagulation (eg. mechanical heart valve, atrial fibrillation) or ADP receptor antagonist (eg. drugeluting stent) History of bleeding diathesis, significant GI bleed, ICH, or liver failure Allergy to or intolerance of aspirin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>coronary artery bypass grafting</keyword>
</DOC>